|
Volumn 46, Issue , 2008, Pages
|
Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL PHARMACOLOGY;
COST BENEFIT ANALYSIS;
DRUG DEVELOPMENT;
ECONOMICS;
EDITORIAL;
HUMAN;
METHODOLOGY;
COST-BENEFIT ANALYSIS;
DRUG DISCOVERY;
HUMANS;
PHARMACOLOGY, CLINICAL;
|
EID: 77953636961
PISSN: 00796468
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (2)
|
References (0)
|